Genprex (GNPX) Stock: Buy, Sell, or Hold?
$2.09
+0.03 (+1.46%)
â˛
5d:
-9.52%
30d:
-22.3%
90d:
-55.81%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
47/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.97 â $2.54
Position: SLIGHTLY LOW
Forward P/E & Valuation
-1.8x
Next 12M consensus est.
Wall Street Target
$7.50
+258.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.83 / $2.38
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: GNPX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When GNPX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GNPX is currently trading at $2.09, which is considered slightly low relative to its 30-day fair value range of $1.97 to $2.54.
Technical Outlook: Technically, GNPX is in a strong downtrend. Immediate support is located at $1.83, while resistance sits at $2.38.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.50 (+258.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GNPX is in a strong downtrend. Immediate support is located at $1.83, while resistance sits at $2.38.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.50 (+258.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.97 -
$2.54
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$1.97 -
$2.54
Current vs Trading Range
SLIGHTLY LOW
Support Level
$1.83
Resistance Level
$2.38
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 258.9% below Wall St target ($7.50)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.82
Wall Street Target
$7.50
(+258.9%)
Share GNPX Analysis
Share this live GNPX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GNPX)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment dominates $GNPX on StockTwits, with traders urging against riding stocks down. No recent news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 10:36 PM ET
Data refreshes hourly during market hours. Next update: 11:36 PM
Data refreshes hourly during market hours. Next update: 11:36 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GNPX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$978 | 37 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 43 HOLD |
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
21 analysts |
$650 | 36 SELL |
|
NAMS
NewAmsterdam Pharma CompâĻ |
STRONG BUY
16 analysts |
$50 | 49 HOLD |
|
CGEM
Cullinan Oncology LLC |
STRONG BUY
12 analysts |
$35 | 57 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GNPX Research Pages
